S&P 500   4,575.76 (+0.02%)
DOW   35,671.02 (-0.24%)
QQQ   380.77 (+0.44%)
AAPL   148.80 (-0.35%)
MSFT   323.58 (+4.34%)
FB   314.71 (-0.35%)
GOOGL   2,887.55 (+3.64%)
TSLA   1,058.55 (+3.94%)
AMZN   3,388.00 (+0.35%)
NVDA   248.25 (+0.44%)
BABA   169.62 (-0.22%)
NIO   40.17 (-0.74%)
CGC   13.00 (-1.29%)
GE   104.75 (-2.50%)
AMD   124.70 (+1.44%)
MU   67.73 (-1.76%)
T   25.22 (-0.59%)
F   15.69 (-1.57%)
ACB   6.93 (-1.42%)
DIS   169.75 (-1.33%)
PFE   42.73 (-1.91%)
BA   206.27 (-1.69%)
AMC   35.38 (-1.86%)
S&P 500   4,575.76 (+0.02%)
DOW   35,671.02 (-0.24%)
QQQ   380.77 (+0.44%)
AAPL   148.80 (-0.35%)
MSFT   323.58 (+4.34%)
FB   314.71 (-0.35%)
GOOGL   2,887.55 (+3.64%)
TSLA   1,058.55 (+3.94%)
AMZN   3,388.00 (+0.35%)
NVDA   248.25 (+0.44%)
BABA   169.62 (-0.22%)
NIO   40.17 (-0.74%)
CGC   13.00 (-1.29%)
GE   104.75 (-2.50%)
AMD   124.70 (+1.44%)
MU   67.73 (-1.76%)
T   25.22 (-0.59%)
F   15.69 (-1.57%)
ACB   6.93 (-1.42%)
DIS   169.75 (-1.33%)
PFE   42.73 (-1.91%)
BA   206.27 (-1.69%)
AMC   35.38 (-1.86%)
S&P 500   4,575.76 (+0.02%)
DOW   35,671.02 (-0.24%)
QQQ   380.77 (+0.44%)
AAPL   148.80 (-0.35%)
MSFT   323.58 (+4.34%)
FB   314.71 (-0.35%)
GOOGL   2,887.55 (+3.64%)
TSLA   1,058.55 (+3.94%)
AMZN   3,388.00 (+0.35%)
NVDA   248.25 (+0.44%)
BABA   169.62 (-0.22%)
NIO   40.17 (-0.74%)
CGC   13.00 (-1.29%)
GE   104.75 (-2.50%)
AMD   124.70 (+1.44%)
MU   67.73 (-1.76%)
T   25.22 (-0.59%)
F   15.69 (-1.57%)
ACB   6.93 (-1.42%)
DIS   169.75 (-1.33%)
PFE   42.73 (-1.91%)
BA   206.27 (-1.69%)
AMC   35.38 (-1.86%)
S&P 500   4,575.76 (+0.02%)
DOW   35,671.02 (-0.24%)
QQQ   380.77 (+0.44%)
AAPL   148.80 (-0.35%)
MSFT   323.58 (+4.34%)
FB   314.71 (-0.35%)
GOOGL   2,887.55 (+3.64%)
TSLA   1,058.55 (+3.94%)
AMZN   3,388.00 (+0.35%)
NVDA   248.25 (+0.44%)
BABA   169.62 (-0.22%)
NIO   40.17 (-0.74%)
CGC   13.00 (-1.29%)
GE   104.75 (-2.50%)
AMD   124.70 (+1.44%)
MU   67.73 (-1.76%)
T   25.22 (-0.59%)
F   15.69 (-1.57%)
ACB   6.93 (-1.42%)
DIS   169.75 (-1.33%)
PFE   42.73 (-1.91%)
BA   206.27 (-1.69%)
AMC   35.38 (-1.86%)
NASDAQ:HRTX

Heron Therapeutics Insider Trades

$10.87
+0.62 (+6.05 %)
(As of 10/27/2021 10:57 AM ET)
Add
Compare
Today's Range
$10.36
$10.95
50-Day Range
$10.13
$12.74
52-Week Range
$9.87
$22.40
Volume34,475 shs
Average Volume1.35 million shs
Market Capitalization$1.11 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.39

Heron Therapeutics (NASDAQ:HRTX) Insider Buying and Selling Activity

4.63% of Heron Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, Heron Therapeutics insiders have sold shares 7 time(s), totalling $129,979.43. Insiders that have sold shares include Waage Christian, Kimberly Manhard, Craig A Johnson, and David Leslie Szekeres.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter


Heron Therapeutics (NASDAQ HRTX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/21/2021Waage ChristianDirectorSell300$12.31$3,693.00  
6/21/2021Waage ChristianDirectorSell300$15.20$4,560.003,800  
5/3/2021Kimberly ManhardEVPSell1,529$17.66$27,002.143,163  
4/15/2021Waage ChristianDirectorSell300$17.51$5,253.004,100  
4/6/2021Craig A JohnsonDirectorSell250$17.22$4,305.003,590  
1/14/2021David Leslie SzekeresCOOSell827$18.09$14,960.431,250  
1/8/2021David Leslie SzekeresCOOSell3,571$19.66$70,205.86  
5/1/2020Kimberly ManhardVPSell1,158$13.97$16,177.261,158  
11/29/2019Kimberly ManhardVPSell24,000$26.00$624,000.0024,000  
10/4/2019Kevin C TangDirectorBuy285,714$17.50$4,999,995.00  
10/3/2019Barry D QuartCEOBuy4,571$17.50$79,992.5090,081  
10/3/2019John PoyhonenEVPBuy5,143$17.50$90,002.5018,143  
9/30/2019John PoyhonenInsiderBuy11,105$22.62$251,195.10
5/22/2019John PoyhonenDirectorBuy3,000$17.55$52,650.0013,000  
5/15/2019Waage ChristianDirectorBuy1,400$18.04$25,256.001,400  
5/1/2019Kimberly ManhardVPSell1,109$18.86$20,915.741,109  
11/2/2018Kimberly ManhardVPSell494$30.62$15,126.28494  
10/1/2018Kimberly ManhardVPSell6,000$32.07$192,420.006,000  
9/12/2018Kevin C TangDirectorSell2,695,000$35.75$96,346,250.00  
7/2/2018Kimberly ManhardVPSell6,000$37.53$225,180.006,000  
7/2/2018Robert HoffmanCFOSell30,000$38.17$1,145,100.001,280  
7/2/2018Robert RosenPresidentSell225,000$38.98$8,770,500.00132,109  
6/29/2018Robert RosenPresidentSell129,469$39.59$5,125,677.71132,109  
6/21/2018Barry D QuartCEOSell50,000$39.05$1,952,500.0069,600  
3/29/2018Kevin C TangDirectorBuy192,308$26.00$5,000,008.00  
3/19/2018Barry D QuartCEOSell100,000$29.75$2,975,000.00167,993  
3/19/2018Kimberly ManhardVPSell18,000$30.00$540,000.0018,000  
3/14/2018Barry D QuartCEOSell100,000$24.75$2,475,000.00167,993  
1/10/2018Kimberly ManhardVPSell7,584$20.00$151,680.007,584  
4/24/2017Kimberly ManhardVPSell21,542$15.33$330,238.865,250  
1/19/2017Kevin C TangDirectorBuy2,459,016$12.20$29,999,995.20  
8/10/2016Robert RosenInsiderSell100,000$23.30$2,330,000.00102,640  
4/21/2016Robert RosenPresidentSell200,000$23.23$4,646,000.00178,968  
6/10/2015Kevin C TangDirectorBuy121,212$24.75$2,999,997.00  
6/2/2015Kevin C TangDirectorBuy150,000$20.62$3,093,000.00  
6/1/2015Kimberly ManhardDirectorSell2,708$21.17$57,328.36  
6/25/2014Barry D QuartCEOBuy10,000$11.75$117,500.00  
6/25/2014Kevin C TangDirectorBuy510,638$11.75$5,999,996.50  
11/20/2013Barry D QuartCEOBuy1,000,000$0.40$400,000.00  
(Data available from 1/1/2013 forward)












Heron Therapeutics (NASDAQ:HRTX) Insider Trade Frequently Asked Questions

Who is on Heron Therapeutics's Insider Roster?

The list of insiders at Heron Therapeutics includes Barry D Quart, Craig A Johnson, David Leslie Szekeres, John Poyhonen, Kevin C Tang, Kimberly Manhard, and Waage Christian.Learn more on HRTX's insiders

What percentage of Heron Therapeutics stock is owned by insiders?

4.63% of Heron Therapeutics stock is owned by insiders. Learn more on HRTX's insider holdings

Which Heron Therapeutics insiders have been selling company stock?

The following insiders have sold Heron Therapeutics stock in the last 24 months: Craig A Johnson ($4,305.00), David Leslie Szekeres ($85,166.29), Kimberly Manhard ($667,179.40), and Waage Christian ($13,506.00).

How much insider selling is happening at Heron Therapeutics?

Insiders have sold a total of 32,235 Heron Therapeutics shares in the last 24 months for a total of $770,156.69 sold.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.